Key facts
- This page summarizes Invus Public Equities, L.P.'s Form 4 filing for GLYCOMIMETICS INC (GLYC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2024, 16:30.
Invus Public Equities, L.P. - 07 Aug 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GLYC
- Reported as of
- 07 Aug 2024
- Net transaction value
- -$61,206
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2024, 16:30:11 UTC
- Prior SEC filing
- 07 Aug 2024
- Next SEC filing
- 27 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- Invus Public Equities, L.P., By: Invus Public Equities Advisors, LLC, its General Partner, By: /s/ Raymond Debbane, President
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Invus Public Equities, L.P. filed Form 4 for GLYCOMIMETICS INC (GLYC) on 09 Aug 2024.
Change
- Previous filing in this sequence was filed on 07 Aug 2024.
- Current net transaction value: -$61,206.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLYC
transaction
Common Stock
Sale
- Transaction value
- $11,197
- Shares
- -61,488
- Change %
- -0.93%
- Price
- $0.1821
- Shares after
- 6,578,438
- Date
- 07 Aug 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
GLYC
transaction
Common Stock
Sale
- Transaction value
- $50,009
- Shares
- -260,873
- Change %
- -4%
- Price
- $0.1917
- Shares after
- 6,317,565
- Date
- 08 Aug 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Invus Public Equities, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. Invus Global Management, LLC is the managing member of Invus Public Equities Advisors, LLC. Siren, L.L.C. is the managing member of Invus Global Management, LLC. Mr. Raymond Debbane is the managing member of Siren, L.L.C.
Footnote F2
Each of the reporting persons (other than to the extent it directly holds securities reported herein), disclaims beneficial ownership of the securities held by the other reporting persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.175 to $0.1855 per share, inclusive. The reporting persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.18 to $0.1978 per share, inclusive. The reporting persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.